(Group leaders Dr. Johanna Berg, Dr. Beatrice Tolksdorf).

We develop 3D organ models. Modern 3D bio-printing techniques are used to generate and physiologically characterize human models for the lung and liver.
We then use the organ models for further studies, for example for infection experiments and for the use of RNA interference (RNAi) technology as an antiviral strategy.

(Head Dr. H. Fechner)

Development of oncolytic Coxsackie B3 viruses for the treatment of tumor diseases
Development of anti-adenoviral therapies for the treatment of severe systemic adenovirus infections in immunocompromised patients